The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Feb. 22, 9:39 AM

Slide #3. Ascendis Pharma A/S Secondary Offering

Company: Ascendis Pharma A/S (NASDAQ:ASND)
Date announced: 2/20/2018
Secondary Offering Details: Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000,000 of American Depositary Shares ("ADSs"), each of which represents one ordinary share of Ascendis. All of the ADSs are being offered by Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional $22,500,000 of ADSs at the public offering price, less the underwriting commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Ascendis Pharma is a biotechnology pharmaceutical company based in Denmark. Co. is engaged in developing differentiated prodrug versions of high-value drugs. Co.'s proprietary TransCon technology is used to generate product candidates that are improved versions of existing drugs for use in the treatment of pediatric growth hormone deficiency, adult growth hormone deficiency, pulmonary arterial hypertension, diabetes and Ophthalmology. Co. creates long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Co. maintains offices in Palo Alto, California and research and clinical development sites in Heidelberg, Germany and Copenhagen.
Open the ASND Page at The Online Investor »

Company Name: 
Ascendis Pharma A/S
Drugs & Pharmaceuticals
Number of ETFs Holding ASND: 
Total Market Value Held by ETFs: 

Open the ASND Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (3.60 out of 4)
72nd percentile
(ranked higher than approx. 72% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page |

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.